Epidemiology & Risk Factors
Definition: Development of secondary sexual characteristics in girls <8 yo or boys <9 yo .
Central PP (gonadotropin-dependent):
Girls: >90% idiopathic.
Boys: >90% secondary to CNS lesions (e.g., hypothalamic hamartoma, astrocytoma, trauma, cranial irradiation).
Peripheral PP (gonadotropin-independent):
Caused by autonomous sex hormone secretion (gonads, adrenals, or exogenous exposure).
Associated w/ McCune-Albright syndrome , CAH , Leydig cell tumors, granulosa cell tumors.
Clinical Features
Accelerated growth velocity & advanced skeletal maturation.
Girls: Thelarche (breast development), pubarche (pubic hair), menarche.
Boys: Testicular enlargement (testicular volume >4 mL or length >2.5 cm), phallic enlargement, pubarche, voice deepening, acne .
Signs of underlying pathology:
Café-au-lait spots w/ irregular borders (McCune-Albright).
Focal neurologic deficits, headaches , or signs of ↑ ICP (CNS tumor).
Virilization/hirsutism in girls (CAH or adrenal tumor).
Diagnosis
Initial : Bone age (BA) radiograph (left hand/wrist).
If BA ≤ chronological age (CA): Likely normal variant (e.g., premature thelarche/adrenarche). c
If BA > CA: Assess gonadotropins.
Key Labs : Basal LH level.
If high: Central PP.
If low: Perform GnRH stimulation test .
LH rises (pubertal response) -> Central PP.
LH remains low (prepubertal response) -> Peripheral PP.
Imaging & Further Workup :
Central PP: Brain MRI w/ contrast (rule out hypothalamic hamartoma or CNS tumor).
Peripheral PP:
Girls: Pelvic US (ovarian cysts, granulosa cell tumor ).
Boys: Testicular US (Leydig cell tumor).
Both: Serum DHEA-S, 17-OHP, testosterone levels (evaluate for CAH or adrenal tumors).
Differential Diagnostics
Premature adrenarche : Isolated pubic/axillary hair + body odor; BA normal or slightly advanced; normal basal LH.
Premature thelarche : Isolated breast development; BA matches CA; normal basal LH.
McCune-Albright syndrome : Triad of peripheral PP, irregular café-au-lait spots (coast of Maine) , and polyostotic fibrous dysplasia (recurrent bone fractures).
Congenital Adrenal Hyperplasia (CAH) : Peripheral PP + virilization + electrolyte abnormalities (salt-wasting 21-hydroxylase deficiency); elevated 17-OHP.
Management
Central PP :
GnRH receptor agonists (e.g., depot leuprolide ) continuous therapy to downregulate GnRH receptors, suppressing LH/FSH secretion.
Prevents premature epiphyseal fusion and maximizes adult height.
Peripheral PP :
Treat primary cause.
Exogenous hormone exposure: Remove source.
CAH: Glucocorticoids (hydrocortisone).
Tumors (Leydig/granulosa cell): Surgical resection.
McCune-Albright: Aromatase inhibitors (e.g., anastrozole) or SERMs (e.g., tamoxifen).
Complications
Premature epiphyseal plate fusion resulting in short adult stature .
Psychosocial distress, bullying, and early sexualization.
CNS mass complications (e.g., hydrocephalus, vision loss) if central tumor etiology.
Benign Variants of Puberty
Benign variants of puberty are self-limiting, non-progressive patterns of early sexual development.
Bone age is typically normal (equal to chronological age), and growth velocity is within normal limits.
Epidemiology & Risk Factors
Premature Thelarche (PT) : Girls <2 yo.
Premature Adrenarche (PA) : Girls <8 yo, boys <9 yo; RFs: Obesity, SGA history.
Constitutional Delay of Growth and Adolescence (CDGA) : Boys > girls; FHx of “late bloomers.”
Clinical Features
PT : Isolated breast development (bilateral or unilateral). No pubic/axillary hair.
PA : Isolated pubic/axillary hair , apocrine body odor, mild acne. Normal breast/testicular volume. c
CDGA : Delayed puberty (girls >13, boys >14), short stature, but normal growth velocity (parallel to growth curve).
Diagnosis
Initial : Bone Age (BA) X-ray (rules out true precocious puberty).
PT & PA: BA = Chronological age (normal).
CDGA: BA < Chronological age (delayed, matches height age).
Labs : Prepubertal LH/FSH. Slightly elevated DHEAS for age in PA (normal 17-OHP).
Growth Velocity : Normal (differentiates from true precocious puberty).
Differential Diagnostics
Central Precocious Puberty : Diff by advanced BA , accelerated growth , and ↑ LH (basal or GnRH-stimulated).
Peripheral Precocious Puberty : Diff by advanced BA , accelerated growth , and low LH (suppressed by peripheral sex steroids).
Hypogonadotropic Hypogonadism : Diff from CDGA by lack of growth spurt, persistently low gonadotropins, or associated anosmia (Kallmann).
Management
First-line (PT & PA) : Reassurance and observation every 3-6 mos. c
First-line (CDGA) : Reassurance & monitoring (reassure that normal final adult height is achieved).
Refractory/Psychosocial distress (CDGA in boys >14 yo) : Short-course low-dose testosterone .
Complications
PA: Increased risk of PCOS and metabolic syndrome later in life.
CDGA: Severe psychosocial distress, low self-esteem.